SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cytoclonal Pharmaceutics INC.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maurice Winn who wrote (1)9/7/1999 8:34:00 PM
From: JOHN ASHBOLT  Read Replies (1) of 6
 
Thankyou for pointing that out and I apologise to the thread for the incorrect spelling of telomerase. HOWEVER, my computer is a pre 60s model and when I pressed submit the whole post vanished so it became a matter of submit and hope.

Cytoclonal recently purchased a novel computed aided technology for designing new drugs called Quantum Core Technology QCT. QCT was developed by Dr Dorit Arid, previously of Tel Aviv University. He has moved to Dallas and joined CYPH as Vice President of drug design.

QCT is a novel technology which designs drugs utilising high powered computers based on the molecular mechanism of the targets. He has developed several lead compounds including one for the treatment of AIDS. Compounds for the treatment of cancer and the COMMON COLD are presently being developed.

Just a little on QCT, may help to answer your query.
It is not all Yew trees and weeping willows.

Regards John.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News